ArticleFrontiers in chemistry2018

Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development.

Eszter Ostorhazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.